DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sherman MM, Ungureanu S, Rey JA.
Naltrexone/Bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults.
P&T 2016;
41 (03) 164-172
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.